0001209191-23-028505.txt : 20230510
0001209191-23-028505.hdr.sgml : 20230510
20230510165137
ACCESSION NUMBER: 0001209191-23-028505
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230508
FILED AS OF DATE: 20230510
DATE AS OF CHANGE: 20230510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHERMAN MARK ANDREW
CENTRAL INDEX KEY: 0001256708
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 23907374
MAIL ADDRESS:
STREET 1: DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-08
0
0001308547
Dolby Laboratories, Inc.
DLB
0001256708
SHERMAN MARK ANDREW
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
0
1
0
0
EVP, Gen. Counsel & Secretary
0
Class A Common Stock
2023-05-08
4
M
0
11118
45.50
A
67492
D
Class A Common Stock
2023-05-08
4
M
0
3882
62.32
A
71374
D
Class A Common Stock
2023-05-08
4
S
0
12820
83.4653
D
58554
D
Class A Common Stock
2023-05-08
4
S
0
2180
84.3527
D
56374
D
Employee Stock Option (right to buy)
45.50
2023-05-08
4
M
0
11118
0.00
D
2026-12-15
Class A Common Stock
11118
0
D
Employee Stock Option (right to buy)
62.32
2023-05-08
4
M
0
3882
0.00
D
2024-12-15
Class A Common Stock
3882
22998
D
Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
The shares were sold in multiple transactions at prices ranging from $83.07 to $84.015, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
The shares were sold in multiple transactions at prices ranging from $84.10 to $84.735, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
This option was originally granted for a total of 52,000 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.
This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.
/s/ Daniel Rodriguez, Attorney-in-Fact for Andy Sherman
2023-05-10